Inventor · disambiguated record
Fumiaki Kikuchi
Also filed as: KIKUCHI FUMIAKI
10 granted patents·5 pending applications·24 citations·filing 2013–2022
84Inventor score
Top patents by PatentIndex Score
15 records- 0188US10435399B2HDAC6 inhibitory heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 8, 2019·5 cites·17 claims
- 0285US9371320B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jun 21, 2016·10 cites·8 claims
- 0382US9346776B2Fused heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2015·Granted May 24, 2016·4 cites·3 claims
- 0476US9428470B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 30, 2016·2 cites·3 claims
- 0575US9975903B2Condensed heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted May 22, 2018·2 cites·11 claims
- 0674US10017487B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 10, 2018·1 cites·16 claims
- 0756US2023037538A1Anti-als compoundsTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 0853US2022370491A1Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 0949US12084436B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 10, 2024·0 cites·16 claims
- 1049US2022289679A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 1146US10023544B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jul 17, 2018·0 cites·8 claims
- 1245US9969705B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted May 15, 2018·0 cites·9 claims
- 1343US2022089525A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 1443US2016251352A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Application pending·0 cites
- 1542US11459325B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 4, 2022·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Fumiaki Kikuchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →